Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3695428015 | Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3695429011 | Estradiol 2.083 microgram/hour and norethindrone acetate 10.417 microgram/hour prolonged-release transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3695430018 | Product containing precisely estradiol 2.083 microgram/1 hour and norethisterone acetate 10.417 microgram/1 hour prolonged-release transdermal patch (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has manufactured dose form | Prolonged-release transdermal patch (dose form) | true | Inferred relationship | Some | ||
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has concentration strength denominator value | en | false | Inferred relationship | Some | 2 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Is a | Product containing estradiol and norethisterone (medicinal product) | false | Inferred relationship | Some | ||
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has basis of strength substance (attribute) | Norethisterone acetate | false | Inferred relationship | Some | 2 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has concentration strength denominator value | en | false | Inferred relationship | Some | 1 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has concentration strength numerator value | 10.417 | false | Inferred relationship | Some | 2 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Is a | Estradiol-containing product in transdermal dose form | false | Inferred relationship | Some | ||
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has basis of strength substance (attribute) | Estradiol | false | Inferred relationship | Some | 1 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has precise active ingredient | Norethisterone acetate | false | Inferred relationship | Some | 2 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Count of base of active ingredient | to | false | Inferred relationship | Some | ||
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has concentration strength numerator value | 2.083 | false | Inferred relationship | Some | 1 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has precise active ingredient | Estradiol | false | Inferred relationship | Some | 1 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has concentration strength denominator unit | hour | true | Inferred relationship | Some | 1 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has concentration strength denominator unit | hour | true | Inferred relationship | Some | 2 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Is a | Product containing only estradiol and norethisterone in transdermal dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Is a | Progesterone receptor agonist-containing product | false | Inferred relationship | Some | ||
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has precise active ingredient | Norethisterone acetate | true | Inferred relationship | Some | 1 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has basis of strength substance (attribute) | Norethisterone acetate | true | Inferred relationship | Some | 1 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has basis of strength substance (attribute) | Estradiol | true | Inferred relationship | Some | 2 | |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch | Has precise active ingredient | Estradiol | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR